Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00680992
First received: May 15, 2008
Last updated: November 19, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)